NCT00066599View on ClinicalTrials.gov

Voriconazole in Preventing Fungal Infections in Children With Neutropenia After Chemotherapy

PHASE2CompletedINTERVENTIONAL
Timeline

Start Date

June 30, 2003

Study Completion Date

June 30, 2004

Conditions
Kidney CancerLeukemiaLymphomaMultiple Myeloma and Plasma Cell NeoplasmMyelodysplastic SyndromesMyelodysplastic/Myeloproliferative NeoplasmsNeuroblastomaNeutropeniaSarcoma
Interventions
DRUG

voriconazole

Trial Locations (7)

27710

Duke Comprehensive Cancer Center, Durham

75390

Simmons Cancer Center at University of Texas Southwestern Medical Center - Dallas, Dallas

92868

Children's Hospital of Orange County, Orange

92123-4282

Children's Hospital and Health Center, San Diego, San Diego

20892-1182

Warren Grant Magnuson Clinical Center - NCI Clinical Studies Support, Bethesda

44106-5065

Ireland Cancer Center, Cleveland

19104-4318

Children's Hospital of Philadelphia, Philadelphia

All Listed Sponsors
lead

National Cancer Institute (NCI)

NIH

NCT00066599 - Voriconazole in Preventing Fungal Infections in Children With Neutropenia After Chemotherapy | Biotech Hunter | Biotech Hunter